N
NVO
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
1Mentions1Articles1Stories0Events0.00Salience
30-day activity pulse
Recent
8
Baseline
23
Ratio
0.34x
Peak
4
Peak article volume on 2026-04-02.
Event Map
Event Timeline
🇺🇸USA
cameoplus · 2026-04-23
Vaccine or treatment milestone in Washington, D.C.
U.S. Medicare to cover GLP-1 drug costs for eligible seniors
🇺🇸USA
cameoplus · 2026-04-15
AI Capability Event in San Francisco
OpenAI launches less restricted GPT-5.4 Cyber model, not in ChatGPT
🇨🇦CAN
cameoplus · 2026-04-03
Host a visit in Montreal
Ottawa launches task force with drug companies to prepare for USMCA talks
🇺🇸USA
cameoplus · 2026-04-03
Trade Policy Action in Washington, D.C.
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary
🇨🇦CAN
cameoplus · 2026-04-02
Capital Allocation Event in British Columbia
Canada announces $127 million investment in Aspect Biosystems and Providence Health Care
🇨🇦CAN
cameoplus · 2026-04-02
Capital Allocation Event in British Columbia
Aspect Biosystems inks $280 million partnership with Canada to advance development
🇺🇸USA
cameoplus · 2026-04-02
Trade Policy Action (tariffs imposed) in Washington, D.C.
Trump imposes 100% tariffs on drugmakers that won’t cut prices